Targeting the expression of T antigens with selinexor (KPT‐330) shows promise for Merkel cell polyomavirus‐positive Merkel cell carcinoma treatment. (1st June 2021) - Gupta, R.; Simonette, R.A.; Doan, H.Q.; Rady, P.L.; Tyring, S.K.